Gastric inhibitory peptidereleased by Gastric Inhibitory Peptide: Understanding Its Actions and Significance
Gastric inhibitory peptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is a crucial hormone produced in the upper small intestine.作者：K Suzuki·2013·被引用次数：116—Gastric inhibitory polypeptide(GIP) is an incretin released from enteroendocrine K-cells in response to nutrient ingestion.GIPpotentiates ... Its primary role is to regulate blood glucose levels by potentiating glucose-stimulated insulin secretion from pancreatic beta cells. Beyond this well-established function, GIP also influences other physiological processes, including gastric acid secretion, glucagon and somatostatin release, and adipocyte biology. Understanding the multifaceted gastric inhibitory peptide action is key to appreciating its significance in metabolic health and disease.
Originally identified for its ability to inhibit gastric acid secretion, GIP's most prominent action is its role as an incretin2021年6月27日—Activation of the pathway results in the induction of SOCS3 and reduces neural leptin and insulinactions, thereby mediating dietary obesity.. Incretins are gut hormones released in response to nutrient ingestion, and they enhance insulin secretion in a glucose-dependent manner.Roche's Obesity Drug Shows 22.5% Weight Loss in Phase ... This means that GIP primarily stimulates insulin release when blood glucose levels are elevated, thereby preventing excessive post-meal hyperglycemia.作者：K Osei·1985·被引用次数：8—GIP stimulates insulin release in the presence of hyperglycemiaand as such is considered a major enteroinsular hormone. Since elevated glucose and insulin ... This glucose-dependent stimulation is a vital safeguard against dangerously high blood sugar.
While its inhibitory effect on gastric acid secretion is weaker compared to other hormones, it remains a recognized function.GIP (Gastric Inhibitory Polypeptide) Assay Services - BPS Bioscience This action contributes to the overall regulation of digestion by modulating the rate at which food leaves the stomach and the secretion of digestive acids.The evolving story of incretins (GIP and GLP‐1) in metabolic ...
GIP exerts its effects by binding to a specific receptor, the GIP receptor (GIPR), which is a G protein-coupled receptor found on various cell types, including pancreatic beta cells, adipocytes, and even in the central nervous system. Upon activation, the GIPR triggers intracellular signaling cascades, notably involving adenylate cyclase and cyclic adenosine monophosphate (cAMP), which ultimately mediate the peptide's diverse actions. The presence of GIP receptors in the brain also suggests potential roles in appetite regulation and metabolism beyond its direct effects on the pancreas.
Recent research has illuminated additional actions of GIP, expanding our understanding of its physiological importanceThe Role of GIP Receptor in the CNS for the Pathogenesis of .... GIP has been shown to stimulate the secretion of glucagon and somatostatin from pancreatic islet cells. While glucagon generally raises blood glucose, its secretion in conjunction with insulin release from GIP stimulation can contribute to a balanced metabolic response. Furthermore, GIP plays a role in adipocyte biology, influencing fat storage and metabolism.GIP (Gastric Inhibitory Polypeptide) Assay Services - BPS Bioscience
Emerging evidence also points to non-insulinotropic actions of GIP and GLP-1 (glucagon-like peptide-1), another major incretin hormoneGastric inhibitory polypeptide. These actions can include effects on pancreatic beta-cell proliferation and survival, suggesting a broader impact on pancreatic healthThe primary action of GIP is thestimulation of glucose-dependent insulin secretion. GIP may also play a role in adipocyte biology. Cat.. The interplay between GIP and GLP-1 is an active area of research, with both hormones contributing to the regulation of satiety, nausea, and appetite.
The significant role of GIP in glucose homeostasis and metabolism has positioned it as a promising therapeutic target for conditions like type 2 diabetes and obesityThe Role of GIP in the Regulation of GLP-1 Satiety and Nausea | Diabetes. Strategies aimed at modulating GIP action, such as blocking its activity to counter insulin resistance or developing dual GIP/GLP-1 receptor agonists, are under investigation. These approaches seek to harness the benefits of incretin signaling for weight management and improved glycemic control. Understanding the intricate gastric inhibitory peptide action provides a foundation for developing innovative treatments for metabolic disorders.